Mesa Laboratories Inc. (MLAB)
$128.65
$1.50
(1.18%)
As on 27-Aug-2026 16:00EDT
Market cap
$698 Mln
Revenue (TTM)
$250 Mln
P/E Ratio
141.8
P/B Ratio
3.5
Div. Yield
0.5 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
18.1
-
Debt to Equity
0.9
-
Book Value
$--
-
EPS
$0.8
-
Face value
--
-
Shares outstanding
5,595,869
10 Years Aggregate
CFO
$234.05 Mln
EBITDA
$179.34 Mln
Net Profit
$52.88 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
| 63.9 | 31.9 | 21.2 | 85.6 | -3.2 | -13.6 | 1.7 |
|
BSE Sensex
| -9.1 | 1.1 | 1.2 | -4.8 | 5.8 | 6.6 | 10.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
| -40.5 | 25.6 | -37.0 | -49.3 | 14.5 | 14.9 | 19.7 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
128.7 | 698.1 | 249.7 | 4.8 | 7.1 | 2.6 | 141.8 | 3.5 |
| 64.9 | 8,484.6 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.1 | |
| 14.6 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 59.3 | 9,074.5 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 181.9 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.5 | 6,525.3 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24 | 5.0 | |
| 89.5 | 5,420.5 | 1,579.2 | 145.6 | 14.3 | 8.9 | 37.2 | 3.2 | |
| 321.0 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 182.0 | 10,222.2 | 785.1 | 41.5 | 9.9 | 2 | 251.6 | 4.8 |
Shareholding Pattern
View DetailsAbout Mesa Laboratories (MLAB)
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control... segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado. Read more
-
CEO, President & Director
Mr. Gary M. Owens
-
CEO, President & Director
Mr. Gary M. Owens
-
Headquarters
Lakewood, CO
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Mesa Laboratories (MLAB)
What is the current share price of Mesa Laboratories Inc (MLAB) Today?
The share price of Mesa Laboratories Inc (MLAB) is $128.65 (NASDAQ) as of 27-Aug-2026 16:00 EDT. Mesa Laboratories Inc (MLAB) has given a return of -3.23% in the last 3 years.
What is the current PB & PE ratio of Mesa Laboratories Inc (MLAB)?
The P/E ratio of Mesa Laboratories Inc (MLAB) is 141.77 times as on 21-Aug-2026, a 219 premium to its peers’ median range of 44.46 times.
The P/B ratio of Mesa Laboratories Inc (MLAB) is 3.54 times as on 21-Aug-2026, a 8 discount to its peers’ median range of 3.84 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
73.03 |
2.63 |
2025 |
-326.35 |
4.03 |
2024 |
-2.33 |
4.07 |
2023 |
1,010.99 |
2.39 |
2022 |
715.60 |
3.40 |
What is the 52 Week High and Low of Mesa Laboratories Inc (MLAB)?
The 52-week high and low of Mesa Laboratories Inc (MLAB) are Rs 129.16 and Rs 59.44 as of 28-Aug-2026.
What is the market cap of Mesa Laboratories Inc (MLAB)?
Mesa Laboratories Inc (MLAB) has a market capitalisation of $ 698 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Mesa Laboratories Inc (MLAB)?
Before investing in Mesa Laboratories Inc (MLAB), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.